Pluribus Labs’s Ventas VTR Stock Holding History

Pluribus Labs’s Portfolio VTR Stock Details VTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$317K	Buy	+6,173	New	+$346K	0.58%	55

Other funds holding VTR

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AAMU

APG Asset Management US New York $13B AUM 5.3% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CIM

Centersquare Investment Management Conshohocken, Pennsylvania $9.67B AUM 5.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Pluribus Labs's VTR Position: Q2 2022 in Review

Pluribus Labs opened a new position in Ventas (VTR) in Q2 2022: 6,173 shares worth $317K. The stake represents 0.58% of the portfolio and ranks #55 among its holdings.

645 funds tracked by Wall St. Rank hold VTR as of Q2 2022.

Pluribus Labs held 6,173 shares of Ventas worth $317K as of Q2 2022.
Ventas was a new Pluribus Labs position in Q2 2022.
Ventas made up 0.58% of Pluribus Labs's portfolio in Q2 2022, its #55 holding.
645 funds tracked by Wall St. Rank held Ventas as of Q2 2022.

Based on Pluribus Labs's 13F filing for Q2 2022, filed 12 Aug 2022.